Regeneron data scientist resume tips and portfolio 2026

Regeneron Data Scientist Resume Tips and Portfolio 2026

TL;DR

Regeneron does not care about generic analytics resumes — they screen for biopharma context, statistical rigor, and translational impact. The strongest data scientist applications show direct alignment with target therapeutic areas and evidence of influencing clinical or operational decisions. Your resume must pass both automated keyword filters and human judgment in a 30-second scan.

Who This Is For

This is for data scientists with 2–7 years of experience transitioning from tech, academia, or CROs into biopharma, specifically targeting Regeneron. You’re not entry-level, but you haven’t yet cracked the unspoken hiring code: Regeneron values scientific precision over flashy dashboards and demands evidence of domain fluency in genomics, immunology, or cardiovascular disease. If your resume reads like it could go to Google or Pfizer interchangeably, it will be rejected.

What does Regeneron look for in a data scientist resume in 2026?

Regeneron’s recruiting team uses an ATS that flags resumes lacking biopharma-specific terminology, statistical methods, and therapeutic area keywords. In a Q3 2025 hiring committee meeting, a candidate with strong Python skills and a top-tier PhD was immediately screened out because their resume mentioned “A/B testing” three times but “mixed-effects models” zero. Not a coding problem — a domain credibility signal failure.

The deeper issue isn’t skill gaps; it’s framing. Regeneron doesn’t want data scientists who “analyze large datasets.” They want candidates who “model longitudinal biomarker trajectories to inform dose selection in Phase 2 trials.” The distinction isn’t semantics — it’s proof of operational familiarity. You’re not selling data wrangling; you’re selling scientific inference under uncertainty.

Not tech adaptability, but therapeutic precision.

Not machine learning breadth, but statistical depth in high-variance biological systems.

Not cross-functional collaboration, but regulatory-aware documentation of model decisions.

In a debrief for a failed DS hire, the hiring manager said, “They knew TensorFlow, but couldn’t explain why a Cox model beats random survival forests in a sparse-event trial.” That’s the bar.

One candidate succeeded by leading their resume with: “Developed Bayesian adaptive trial simulation framework adopted by clinical pharmacology team to reduce sample size by 18% in atopic dermatitis program.” That sentence passed ATS, impressed the scientist reviewer, and triggered a referral. Translation: your first bullet must sound like it belongs in a protocol amendment.

How should I structure my Regeneron data scientist resume?

Put your therapeutic area expertise in the top third — not under skills, not in a summary, but as a headline. Example: “Data Scientist | Oncology & Gene Therapy | Mixed-Effects Modeling | CDISC SDTM.” That’s what gets you past the 30-second screen. Recruiters at Regeneron are trained to look for immediate signals of domain fit — if it takes more than two lines to find it, you’re out.

Reverse-chronological format is required. No designer templates. No icons. No color. One page only if you have under 8 years of experience; two pages only if you have peer-reviewed publications or regulatory submissions. In a 2024 HC debate, a candidate with two pages was approved only because the second page listed FDA submission numbers where their models were cited.

Each role should have 3–5 bullets. First bullet = strategic impact. Last bullet = technical method. Middle bullets = collaboration and governance. Example:

Led statistical modeling for safety signal detection in Phase 3 IL-17 inhibitor trial, reducing false positives by 32% vs. legacy thresholds
Collaborated with medical monitor to align anomaly detection logic with MedDRA coding hierarchy
Implemented generalized estimating equations (GEE) to account for within-patient correlation across visits
Delivered model validation report per 21 CFR Part 11 standards for auditor review

Not “managed data pipelines,” but “ensured audit-ready traceability of model inputs.”

Not “worked with scientists,” but “translated clinical hypotheses into testable statistical frameworks.”

Not “used R and Python,” but “maintained dual R/Python validation suite for audit reconciliation.”

The summary section, if used, must name a therapeutic area and a statistical specialty. “Data scientist applying NLP to EHR data in autoimmune diseases” beats “passionate problem-solver leveraging data to drive impact.”

How important is a portfolio for a Regeneron data scientist role?

A portfolio is not required, but a strategic one can override a weak resume. In a 2025 hiring cycle, a candidate with a mid-tier PhD and no pharma experience was advanced because their GitHub included a re-analysis of a public asthma trial using negative binomial models to handle overdispersed exacerbation counts — identical to a real Regeneron program.

The portfolio must demonstrate three things: biological plausibility, statistical correctness, and regulatory awareness. One candidate included a Jupyter notebook that not only fit a survival model but also documented model assumptions, sensitivity analyses, and limitations in a way that mirrored an ISS section. That notebook was circulated in the hiring committee.

Not a Kaggle solution, but a simulated clinical study report.

Not a Shiny dashboard, but a static, version-controlled R Markdown with CITATION.cff and LICENSE.

Not raw code, but a README that explains the clinical question, the statistical rationale, and the decision implications.

Public repositories with patient data, even if de-identified, are disqualifying. One candidate was blacklisted after submitting a portfolio with synthetic data that too closely resembled a real Regeneron trial — the pattern of missingness gave it away. The lesson: when simulating, add noise, change endpoints, and avoid real drug names.

The best portfolios are private, shared via link only after initial screening. They include:

One full analysis from question to inference, with code, data schema, and write-up
A model validation plan (e.g., cross-site performance, temporal drift testing)
A mock table for a clinical study report (e.g., “Table 10.4: Time-to-Event Analysis by Treatment Arm”)

Work through a structured preparation system (the PM Interview Playbook covers biostatistical portfolio design with real debrief examples from Genentech and Regeneron hiring panels).

What technical skills should I highlight for Regeneron DS roles?

Emphasize statistical modeling over machine learning. Regeneron’s data science team runs on SAS, R, and controlled Python environments — not TensorFlow in the cloud. In a 2024 team sync, the head of biostatistics said, “If I see ‘deep learning’ on a DS resume without a single mention of ANCOVA, I assume they don’t understand controlled inference.”

List specific methods, not categories. BAD: “Machine learning.” GOOD: “Random-intercept logistic regression for clustered adverse event data.”

BAD: “Data visualization.” GOOD: “Forest plots for meta-analysis of biomarker subgroups using ggplot2.”

BAD: “Big data tools.” GOOD: “SAS PROC MIXED for repeated-measures analysis in dose-ranging studies.”

SAS is still used in 60% of regulatory submissions. If you have SAS experience, put it in the top third. One candidate got an interview solely because they listed “CDISC ADaM dataset creation” — that skill is in shortage.

Programming languages: R > Python > SAS > SQL. But context matters. “Python for automating CDISC validation checks” beats “Python for building recommendation engines.”

Domain modeling skills trump tool fluency. Regeneron runs on mixed-effects models, survival analysis, Bayesian adaptive designs, and multiplicity adjustments. If your resume doesn’t name at least two of these, it won’t pass the scientist reviewer.

Not “proficient in data cleaning,” but “implemented QC rules for lab data per protocol-specified ranges and delta checks.”

Not “experienced with clinical data,” but “modeled time-dependent covariates in a recurrent event framework for a Phase 4 safety study.”

Not “familiar with biostats,” but “applied gatekeeping procedures to control FWER in a multi-arm trial.”

Certifications: CDMP (Certified Clinical Data Manager) or CCRP adds weight. OSCP or AWS certs do not.

How do I tailor my resume for Regeneron’s therapeutic areas?

You must pick one therapeutic area and go deep. Regeneron’s pipeline is concentrated in immunology (e.g., dupilumab), cardiovascular (e.g., evolocumab), oncology (e.g., linvodacamab), and gene therapy (e.g., RGX-121). Applying generically to “all areas” is a fast track to rejection.

In a 2025 debrief, a hiring manager said, “They listed five therapeutic areas. That tells me they don’t know which science they want to do.” Specialization signals intent and preparedness.

If targeting immunology, mention Th2 pathways, IgE dynamics, or eosinophil count modeling.

For cardiovascular, reference PCSK9 inhibition, LDL-C trajectory modeling, or CVD risk scores.

For oncology, highlight immune-related adverse events (irAEs), RECIST criteria, or tumor growth inhibition models.

For gene therapy, discuss vector copy number, transgene expression kinetics, or immunogenicity risk modeling.

One successful candidate opened their resume with: “Developed joint model of protein C activity and thrombotic event risk in hereditary angioedema patients (n=247), informing endpoint definition for Phase 2.” That specificity matched Regeneron’s HAE program and triggered an immediate interview.

Pull 2–3 recent Regeneron press releases or pipeline updates. Mirror the language. If they say “innate immunity,” don’t say “inflammation.” If they say “lipid metabolism,” don’t say “cholesterol.”

Not “experience in healthcare,” but “modeling of monoclonal antibody pharmacokinetics in chronic inflammatory conditions.”

Not “worked with EHR data,” but “analyzed real-world evidence on biologic switching in moderate-to-severe asthma using Optum data.”

Not “interested in science,” but “published on IL-4Rα polymorphism effects on treatment response in J Allergy Clin Immunol.”

Your resume should read like you’ve already been working on their pipeline for two years.

Preparation Checklist

Align your resume’s first bullet with a current Regeneron clinical program (e.g., Phase 3 trial number, drug mechanism)
Replace generic terms like “insights” or “dashboards” with biopharma-specific outcomes like “informed dose selection” or “supported CSR table generation”
List statistical methods by name (e.g., “Cox proportional hazards,” “negative binomial regression”) — not just “modeling”
Include therapeutic area keywords in your headline and first paragraph (e.g., “Immunology | Cardiovascular | Gene Therapy”)
Remove all non-biopharma projects unless they demonstrate transferable statistical rigor (e.g., survival analysis in churn)
Work through a structured preparation system (the PM Interview Playbook covers biostatistical resume framing with real debrief examples from Regeneron and Merck hiring panels)

Mistakes to Avoid

BAD: “Built a machine learning model to predict patient readmissions using EHR data.”

GOOD: “Applied time-dependent Cox modeling to 12-month post-discharge outcomes in heart failure patients (n=15,200), adjusting for lab trends and medication adherence, with results used to refine risk stratification in a CER study.”

The first sounds like a Kaggle project. The second sounds like a clinical epidemiologist. Regeneron hires the latter.

BAD: “Proficient in Python, R, SQL, and Tableau.”

GOOD: “Developed automated R Markdown pipeline to generate safety monitoring tables for DSMB review, reducing manual effort by 20 hours per cycle.”

Tools are table stakes. Impact in a regulated, team-based environment is what matters.

BAD: “Collaborated with cross-functional teams to deliver data-driven solutions.”

GOOD: “Partnered with clinical pharmacology to validate exposure-response model assumptions using NONMEM, with outputs included in IND amendment.”

Not collaboration as a soft skill, but as a technical co-ownership of regulatory deliverables.

FAQ

Should I include publications on my Regeneron data scientist resume?

Yes — and list them in PubMed format. First-author papers in clinical or statistical journals (e.g., Statistics in Medicine, Clinical Pharmacology & Therapeutics) are weighted heavily. In a 2024 hire, a candidate was selected over three others because their paper on Bayesian dose-escalation designs was cited in a Regeneron trial protocol. If unpublished, list “manuscript in preparation” only if submission is confirmed.

Is SAS still relevant for Regeneron data science roles?

Absolutely. SAS is used in 70% of statistical analysis plans and all primary endpoint analyses for regulatory submission. One candidate was hired specifically to migrate legacy SAS macros to R — their resume highlighted “SAS/STAT, SAS/GRAPH, and macro language fluency.” If you know SAS, put it before Python.

How long does Regeneron’s data scientist hiring process take?

From application to offer: 21–38 days. The process includes 1 recruiter screen (30 min), 1 technical screen (60 min, heavy on stats), and 3–4 onsite rounds (each 45–60 min), including a case exercise. The case is not coding — it’s designing an analysis plan for a simulated trial. In Q2 2025, 68% of candidates failed the case due to ignoring multiplicity or missing covariate adjustment.

Ready to build a real interview prep system?

Get the full PM Interview Prep System →

The book is also available on Amazon Kindle.